1. Home
  2. PRPL vs LUNG Comparison

PRPL vs LUNG Comparison

Compare PRPL & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

HOLD

Current Price

$0.70

Market Cap

76.9M

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.35

Market Cap

72.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
LUNG
Founded
2010
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
72.2M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PRPL
LUNG
Price
$0.70
$1.35
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$1.00
$5.38
AVG Volume (30 Days)
203.9K
680.2K
Earning Date
05-05-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
22.22
7.64
EPS
0.45
N/A
Revenue
$487,877,000.00
$90,497,000.00
Revenue This Year
N/A
$6.20
Revenue Next Year
$12.69
$21.61
P/E Ratio
$1.55
N/A
Revenue Growth
N/A
8.01
52 Week Low
$0.56
$1.31
52 Week High
$1.26
$7.97

Technical Indicators

Market Signals
Indicator
PRPL
LUNG
Relative Strength Index (RSI) 49.25 37.62
Support Level $0.65 N/A
Resistance Level $0.74 $2.01
Average True Range (ATR) 0.04 0.17
MACD 0.00 -0.03
Stochastic Oscillator 55.07 5.29

Price Performance

Historical Comparison
PRPL
LUNG

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: